Biotech | April 12, 2022
ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
The expansion makes Exothera one of the largest viral vector facilities in Europe
Building the future of food in the birthplace of cell-cultured milk
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function
The company has started manufacturing the Sputnik Light vaccine
Subscribe To Our Newsletter & Stay Updated
